Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-20 Sale |
2025-03-24 5:06 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer |
7,602 | $30.02 | $228,250 | 156,667 (Direct) |
View |
| 2025-03-20 Sale |
2025-03-24 5:05 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
20,808 | $30.03 | $624,794 | 103,613 (Direct) |
View |
| 2025-03-11 Sale(A) |
2025-03-18 7:18 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
15,387 | $30 | $461,672 | 126,676 (Direct) |
View |
| 2025-03-14 Sale |
2025-03-18 5:35 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer |
977 | $30 | $29,313 | 164,269 (Direct) |
View |
| 2025-03-14 Sale |
2025-03-18 5:34 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
2,255 | $30 | $67,661 | 124,421 (Direct) |
View |
| 2025-03-06 Sale |
2025-03-13 4:50 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
15,387 | $30 | $461,672 | 126,676 (Direct) |
View |
| 2025-03-11 Sale |
2025-03-13 4:49 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer |
10,445 | $30.01 | $313,413 | 165,246 (Direct) |
View |
| 2025-03-06 Sale |
2025-03-10 4:02 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer |
3,453 | $30 | $103,591 | 175,691 (Direct) |
View |
| 2025-03-06 Sale |
2025-03-10 4:01 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
5,643 | $30 | $169,299 | 142,063 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 6:48 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel |
86,067 | $28.19 | $2,426,634 | 108,137 (Direct) |
View |
| 2025-01-10 Sale |
2025-01-14 4:12 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel |
27,500 | $33.04 | $908,628 | 119,184 (Direct) |
View |
| 2024-09-13 Sale |
2024-09-17 4:32 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer |
9,593 | $36.62 | $351,320 | 53,816 (Direct) |
View |
| 2024-09-05 Sale |
2024-09-06 5:52 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel |
20,225 | $38.26 | $773,792 | 119,184 (Direct) |
View |
| 2024-06-03 Sale |
2024-06-05 4:06 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel |
25,000 | $32.57 | $814,180 | 139,409 (Direct) |
View |
| 2024-05-28 Sale |
2024-05-29 4:29 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer |
19,710 | $34.21 | $674,368 | 130,845 (Direct) |
View |
| 2024-05-23 Sale |
2024-05-28 4:22 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
108,016 | $33.91 | $3,662,548 | 129,693 (Direct) |
View |
| 2024-05-14 Sale |
2024-05-16 7:20 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | BOHLIN GAREN G Director |
28,985 | $32.3 | $936,311 | 52,468 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 4:26 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer |
995 | $36.76 | $36,580 | 63,409 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-28 4:14 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
10,000 | $36.43 | $364,270 | 138,918 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-17 Option Award |
2025-03-19 4:36 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dieter David EVP & General Counsel |
68,449 | $0 | 68,449 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 6:48 pm |
N/A 2028-04-04 |
COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel |
40,000 | $0 | 108,137 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 6:48 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel |
40,000 | $24.03 | 108,137 (Direct) |
View |
| 2025-02-10 Option Award |
2025-02-12 4:10 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
4,820 | $0 | 50,328 (Direct) |
View |
| 2025-02-10 Option Award |
2025-02-12 4:10 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer |
39,075 | $0 | 87,742 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:10 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer |
5,897 | $30.52 | 87,742 (Direct) |
View |
| 2025-02-10 Option Award |
2025-02-12 4:10 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
71,427 | $0 | 147,706 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:10 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
29,623 | $30.52 | 147,706 (Direct) |
View |
| 2025-02-10 Option Award |
2025-02-12 4:10 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer |
78,725 | $0 | 179,144 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:10 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer |
30,426 | $30.52 | 179,144 (Direct) |
View |
| 2025-02-10 Option Award |
2025-02-12 4:09 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel |
69,995 | $0 | 154,204 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:09 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel |
34,975 | $30.52 | 154,204 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-05 5:30 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Lurker Nancy Director |
12,726 | $0 | 12,726 (Direct) |
View |
| 2025-01-10 Exercise |
2025-01-14 4:12 pm |
N/A 2030-02-05 |
COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel |
27,500 | $0 | 119,184 (Direct) |
View |
| 2025-01-10 Exercise |
2025-01-14 4:12 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel |
27,500 | $21.34 | 119,184 (Direct) |
View |
| 2024-11-12 Option Award |
2024-11-14 4:50 pm |
N/A 2034-11-12 |
COLLEGIUM PHARMACEUTICAL INC | COLL | Karnani Vikram President and CEO |
236,316 | $0 | 236,316 (Direct) |
View |
| 2024-05-23 Exercise |
2024-05-28 4:22 pm |
N/A 2028-04-04 |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
75,000 | $0 | 129,693 (Direct) |
View |
| 2024-05-23 Exercise |
2024-05-28 4:22 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
75,000 | $24.03 | 129,693 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-16 7:23 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | SANTINI GINO Director |
7,693 | $0 | 75,656 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-16 7:23 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Melincoff Gwen A Director |
7,693 | $0 | 52,468 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-16 7:23 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | McFarlane Neil F. Director |
7,693 | $0 | 49,365 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-16 7:22 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Freund John Gordon Director |
7,693 | $0 | 95,881 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-16 7:22 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Fallon John A. Director |
7,693 | $0 | 54,843 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-16 7:22 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Balice-Gordon Rita J. Director |
7,693 | $0 | 46,488 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-16 7:21 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director |
7,693 | $0 | 45,508 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-16 7:20 pm |
N/A 2025-03-19 |
COLLEGIUM PHARMACEUTICAL INC | COLL | BOHLIN GAREN G Director |
28,985 | $0 | 52,468 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-16 7:20 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | BOHLIN GAREN G Director |
28,985 | $5.73 | 52,468 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-16 7:20 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | BOHLIN GAREN G Director |
7,693 | $0 | 52,468 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:15 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer |
71,456 | $0 | 150,555 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 4:15 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer |
26,321 | $33.7 | 150,555 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:14 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
67,286 | $0 | 148,918 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 4:14 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer |
29,690 | $33.7 | 148,918 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:14 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer |
35,423 | $0 | 64,404 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 4:14 pm |
N/A N/A |
COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer |
3,199 | $33.7 | 64,404 (Direct) |
View |